Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
10/2010
10/21/2010WO2010118521A1 Peptide ligands for clusterin and uses thereof
10/21/2010WO2009111273A3 Peptide targeting imaging agents and methods of use thereof
10/21/2010US20100266500 Stilbene derivatives and their use for binding and imaging amyloid plaques
10/21/2010US20100266499 Cytokine receptor zcytor17 multimers
10/21/2010US20100266498 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
10/21/2010US20100266497 Internalizing Anti-CD74 Antibodies and Methods of Use
10/21/2010US20100266495 Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal Antibody
10/21/2010US20100266494 Treatment of cancer with novel anti-il13 monoclonal antibodies
10/21/2010US20100266493 Agonist antibodies against tshr
10/21/2010US20100266492 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/21/2010US20100266491 System for targeted delivery of therapeutic agents
10/21/2010US20100266490 Metalloproteinase Binding Proteins
10/21/2010CA2789869A1 Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease
10/21/2010CA2758883A1 Stabilization of radiopharmaceutical compositions using ascorbic acid
10/21/2010CA2756570A1 Peptide ligands for clusterin and uses thereof
10/20/2010EP2240171A2 Inhibitors of carbonic anhydrase ix
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010EP1366366B1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/20/2010CN101868254A Positron emission tomography probes for imaging immune activation and selected cancers
10/20/2010CN101863924A Labeled 99mTc hydrazino-nicotinamide-dioxodecoyl-folic acid coordination compound and preparation method
10/20/2010CN101862463A Preparation method of 18F-labeled nano particle and application thereof
10/19/2010US7816560 N-nonyl-1,5,6-trideoxy-1,5-imino-D-galactitol; N-(7-oxa-nonyl)-1,5,6-trideoxy-1,5-imino-D-galactito; viricide; for treating hepatitis
10/19/2010US7816496 Carbonic anhydrase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/19/2010US7816074 α4 β2 δGABA-A receptors as a strategy for PMS and alcoholism
10/19/2010US7815894 Diagnosis of Alzheimer's disease; binding to a glycerophosphocholine compound
10/19/2010US7815893 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/19/2010CA2411590C Glycopeptide phosphonate derivatives
10/19/2010CA2147499C Prostate-specific membrane antigen
10/14/2010WO2010117984A1 Novel strategies for improved cancer vaccines
10/14/2010WO2010116209A1 Fucoidans as ligands for the diagnosis of degenerative pathologies
10/14/2010WO2010115881A1 Imaging the central nervous system with purinergic p2x7 receptor binding agents
10/14/2010US20100262115 Nanoparticles for cancer sonodynamic and photodynamic therapy
10/14/2010US20100261946 Flexible and/or elastic brachytherapy seed or strand
10/14/2010US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment
10/14/2010US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof
10/14/2010US20100260671 Compounds and methods for the diagnosis and treatment of amyloid associated diseases
10/14/2010US20100260670 ALTERNATIVE SPLICE VARIANT PATTERNS OF HUMAN TELOMERASE REVERSE TRANSCRIPTASE (hTERT) IN THYROID TUMORS TO DISTINGUISH BENIGN FROM MALIGNANT
10/14/2010US20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010US20100260667 Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease
10/14/2010US20100258138 Radiolabeled 1-acetate pet imaging for radiotherapy in head and neck cancer
10/14/2010DE102009007799B4 Molekül zur Funktionalisierung eines Trägers, Bindung eines Radionuklids an den Träger und Radionuklidgenerator zur Herstellung des Radionuklids sowie Herstellungsverfahren Molecule for the functionalization of a carrier, binding of a radionuclide to the carrier, and radionuclide generator for the production of the radionuclide and the production method
10/13/2010EP2239274A1 New methods for diagnosis and treatment of tumours
10/13/2010EP2238139A2 Method for preparing a marked purine derivative, said derivative and uses thereof
10/13/2010CN1976691B Cysteamines for treating complications of hypercholesterolemia and diabetes
10/13/2010CN1798580B Microspheres comprising therapeutic and diagnostic radioactive isotopes
10/13/2010CN1433326B Method for determining viability of myocardial segment
10/13/2010CN101861171A New compositions based on polysaccharides grafted by polyamine or polysulphurised compounds
10/13/2010CN101861170A Improved radiopharmaceutical composition
10/13/2010CN101857561A Preparation method of N-ethyl-N2S2-memantine
10/13/2010CN101856502A Radiolabelled insulin
10/13/2010CN101422623B 99mTc-Trodat-1 marked freeze-dry article medicine-box and preparation method
10/12/2010US7811622 Coated implantable medical device
10/12/2010US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell
10/12/2010US7811551 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/12/2010US7811548 18-[P-(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-8-yl)-phenyl]- octadecyl phosphocholine (CLR1501); endoscopy; colonoscopy; screening tissue targets; skin lesions; administered with antitumor and /or antcarcinogenic agents; near infrared fluorescence; imaging
10/12/2010CA2336114C Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
10/12/2010CA2329751C Substituted porphyrins
10/07/2010WO2010114723A1 Radiolabelling reagents and methods
10/07/2010US20100255558 Supramolecular bioconjugates
10/07/2010US20100254906 New compositions based on polysaccharides grafted by polyamine or polysulphurised compounds
10/07/2010US20100254903 Substituted Aryl-Fluoroborates as Imaging Agents
10/07/2010US20100254902 Stabilization of radiopharmaceuticals
10/07/2010US20100254901 Compositions comprising nucleic acid aptamers
10/07/2010US20100254900 Biocompatible polymers and Methods of use
10/07/2010US20100254899 Radiolabeled affibody molecules
10/07/2010US20100254898 ANTIBODIES THAT BIND GalNAc1-3Gal, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
10/07/2010US20100254897 Seeds and Markers for Use in Imaging
10/07/2010US20100254896 Methods and compositions related to adenoassociated virus-phage particles
10/07/2010DE102009035647A1 Verfahren zum Erzeugen eines Radiopharmakons A method for producing a radiopharmaceutical
10/07/2010CA2757016A1 Radiolabelling reagents and methods
10/06/2010EP2235044A1 New polypeptides having affinity for her2
10/06/2010EP2234647A1 Methods for in vivo atherosclerotic plaque characterization using magnetic susceptibility to identify symptom-producing plaques
10/06/2010EP1283060B1 Preparations for diagnosing infection with helicobacter pylori
10/06/2010CN1711108B Method for the selective and quantitative functionalization of immunoglobulin Fab fragments, conjugate compounds obtained with the same and compositions thereof
10/06/2010CN101854957A Radiofluorination methods
10/06/2010CN101851313A Technetium-99m-marked poly N-vinyl benzyl-D-lactose amide composition and preparation method
10/06/2010CN101850128A 188Re-labelled folic acid coupled cis-platinum magnetic albumin compound nano-particle as well as preparation method and application thereof
10/06/2010CN101084019B Stabilisation of radiopharmaceutical precursors
10/05/2010US7809428 Devices for detection and therapy of atheromatous plaque
10/05/2010US7807135 radiolabeled compounds such as [4-(2-{4-[2-(2-Fluoro-ethoxy)-ethoxy]-phenyl}-vinyl)-phenyl]-methyl-amine, used for the detection of amyloid proteins deposits; medical diagnosis
10/05/2010US7807134 BBN[7-13] peptide as targeting molecule, paclitaxel as therapeutic agent, a polyethylene glycol linker, a lysine or diamino benzoic acid core molecule, biotin as scaffold binding element and streptavidin as the scaffold moiety; anticarcinogenic agents; improved pharmacokinetics; intraveinous injection
10/05/2010US7807133 Diagnosis, therapy of tumors; as compared to avidin, the diavidins have shown ability to increase amount of labelled biotin on target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H
09/2010
09/30/2010WO2010111303A2 Imaging agents for detecting neurological disorders
09/30/2010WO2010111198A1 Compounds compositions and methods of treating cancer and fibrotic diseases
09/30/2010US20100247655 Synthesis of Small Particles
09/30/2010US20100247435 Measurement of neural activity
09/30/2010US20100247434 Anti-Angiogenic Extracts from Pomegranate
09/30/2010US20100247433 Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells
09/30/2010US20100247432 Marker for the diagnosis of cancer
09/30/2010US20100247431 Polypeptides including modified constant regions
09/30/2010US20100247430 Methods and Compositions for Modulating T Cells
09/30/2010US20100247429 Microchip, microchip device and evaporation method using microchip
09/30/2010US20100247427 Methods of inhibiting cell growth and methods of enhancing radiation responses
09/30/2010DE102009015792A1 Inhalable aerosol composition, useful in positron emission tomography, preferably in the medical or veterinary diagnostics e.g. diagnosis of lung function or biological research, comprises gallium-68 labeled carbon particles
09/30/2010CA2756887A1 Indole derivatives
09/30/2010CA2756137A1 Imaging agents for detecting neurological disorders
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 243